169 related articles for article (PubMed ID: 22736462)
1. Mediators of a long-term movement abnormality in a Drosophila melanogaster model of classic galactosemia.
Ryan EL; DuBoff B; Feany MB; Fridovich-Keil JL
Dis Model Mech; 2012 Nov; 5(6):796-803. PubMed ID: 22736462
[TBL] [Abstract][Full Text] [Related]
2. Acute and long-term outcomes in a Drosophila melanogaster model of classic galactosemia occur independently of galactose-1-phosphate accumulation.
Daenzer JM; Jumbo-Lucioni PP; Hopson ML; Garza KR; Ryan EL; Fridovich-Keil JL
Dis Model Mech; 2016 Nov; 9(11):1375-1382. PubMed ID: 27562100
[TBL] [Abstract][Full Text] [Related]
3. A Drosophila melanogaster model of classic galactosemia.
Kushner RF; Ryan EL; Sefton JM; Sanders RD; Lucioni PJ; Moberg KH; Fridovich-Keil JL
Dis Model Mech; 2010; 3(9-10):618-27. PubMed ID: 20519569
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress contributes to outcome severity in a Drosophila melanogaster model of classic galactosemia.
Jumbo-Lucioni PP; Hopson ML; Hang D; Liang Y; Jones DP; Fridovich-Keil JL
Dis Model Mech; 2013 Jan; 6(1):84-94. PubMed ID: 22773758
[TBL] [Abstract][Full Text] [Related]
5. Manganese-based superoxide dismutase mimics modify both acute and long-term outcome severity in a Drosophila melanogaster model of classic galactosemia.
Jumbo-Lucioni PP; Ryan EL; Hopson ML; Bishop HM; Weitner T; Tovmasyan A; Spasojevic I; Batinic-Haberle I; Liang Y; Jones DP; Fridovich-Keil JL
Antioxid Redox Signal; 2014 May; 20(15):2361-71. PubMed ID: 23758052
[TBL] [Abstract][Full Text] [Related]
6. A galactose-1-phosphate uridylyltransferase-null rat model of classic galactosemia mimics relevant patient outcomes and reveals tissue-specific and longitudinal differences in galactose metabolism.
Rasmussen SA; Daenzer JMI; MacWilliams JA; Head ST; Williams MB; Geurts AM; Schroeder JP; Weinshenker D; Fridovich-Keil JL
J Inherit Metab Dis; 2020 May; 43(3):518-528. PubMed ID: 31845342
[TBL] [Abstract][Full Text] [Related]
7. Novel mRNA-Based Therapy Reduces Toxic Galactose Metabolites and Overcomes Galactose Sensitivity in a Mouse Model of Classic Galactosemia.
Balakrishnan B; An D; Nguyen V; DeAntonis C; Martini PGV; Lai K
Mol Ther; 2020 Jan; 28(1):304-312. PubMed ID: 31604675
[TBL] [Abstract][Full Text] [Related]
8. Drosophila melanogaster Models of Galactosemia.
Daenzer JM; Fridovich-Keil JL
Curr Top Dev Biol; 2017; 121():377-395. PubMed ID: 28057307
[TBL] [Abstract][Full Text] [Related]
9. Coordinated movement, neuromuscular synaptogenesis and trans-synaptic signaling defects in Drosophila galactosemia models.
Jumbo-Lucioni PP; Parkinson WM; Kopke DL; Broadie K
Hum Mol Genet; 2016 Sep; 25(17):3699-3714. PubMed ID: 27466186
[TBL] [Abstract][Full Text] [Related]
10. Modifiers of ovarian function in girls and women with classic galactosemia.
Spencer JB; Badik JR; Ryan EL; Gleason TJ; Broadaway KA; Epstein MP; Fridovich-Keil JL
J Clin Endocrinol Metab; 2013 Jul; 98(7):E1257-65. PubMed ID: 23690308
[TBL] [Abstract][Full Text] [Related]
11. Cryptic residual GALT activity is a potential modifier of scholastic outcome in school age children with classic galactosemia.
Ryan EL; Lynch ME; Taddeo E; Gleason TJ; Epstein MP; Fridovich-Keil JL
J Inherit Metab Dis; 2013 Nov; 36(6):1049-61. PubMed ID: 23319291
[TBL] [Abstract][Full Text] [Related]
12. Galactose 1-phosphate accumulates to high levels in galactose-treated cells due to low GALT activity and absence of product inhibition of GALK.
Oh SL; Cheng LY; J Zhou JF; Henke W; Hagen T
J Inherit Metab Dis; 2020 May; 43(3):529-539. PubMed ID: 31774565
[TBL] [Abstract][Full Text] [Related]
13. A pilot study of neonatal GALT gene replacement using AAV9 dramatically lowers galactose metabolites in blood, liver, and brain and minimizes cataracts in GALT-null rat pups.
Rasmussen SA; Daenzer JMI; Fridovich-Keil JL
J Inherit Metab Dis; 2021 Jan; 44(1):272-281. PubMed ID: 32882063
[TBL] [Abstract][Full Text] [Related]
14. The ability of an LC-MS/MS-based erythrocyte GALT enzyme assay to predict the phenotype in subjects with GALT deficiency.
Demirbas D; Huang X; Daesety V; Feenstra S; Haskovic M; Qi W; Gubbels CS; Hecht L; Levy HL; Waisbren SE; Berry GT
Mol Genet Metab; 2019 Apr; 126(4):368-376. PubMed ID: 30718057
[TBL] [Abstract][Full Text] [Related]
15. Involvement of endoplasmic reticulum stress in a novel Classic Galactosemia model.
Slepak TI; Tang M; Slepak VZ; Lai K
Mol Genet Metab; 2007; 92(1-2):78-87. PubMed ID: 17643331
[TBL] [Abstract][Full Text] [Related]
16. The molecular relationship between deficient UDP-galactose uridyl transferase (GALT) and ceramide galactosyltransferase (CGT) enzyme function: a possible cause for poor long-term prognosis in classic galactosemia.
Lebea PJ; Pretorius PJ
Med Hypotheses; 2005; 65(6):1051-7. PubMed ID: 16125333
[TBL] [Abstract][Full Text] [Related]
17. Galactosemia: when is it a newborn screening emergency?
Berry GT
Mol Genet Metab; 2012 May; 106(1):7-11. PubMed ID: 22483615
[TBL] [Abstract][Full Text] [Related]
18. Overelaborated synaptic architecture and reduced synaptomatrix glycosylation in a Drosophila classic galactosemia disease model.
Jumbo-Lucioni P; Parkinson W; Broadie K
Dis Model Mech; 2014 Dec; 7(12):1365-78. PubMed ID: 25326312
[TBL] [Abstract][Full Text] [Related]
19. Neonatal GALT gene replacement offers metabolic and phenotypic correction through early adulthood in a rat model of classic galactosemia.
Daenzer JMI; Rasmussen SA; Patel S; McKenna J; Fridovich-Keil JL
J Inherit Metab Dis; 2022 Mar; 45(2):203-214. PubMed ID: 34964137
[TBL] [Abstract][Full Text] [Related]
20. Grip strength in patients with galactosemia and in a galactose-1-phosphate uridylyltransferase (GALT)-null rat model.
Druss JJ; Rudd Zhong Manis J; Potter NL; Fridovich-Keil JL
J Inherit Metab Dis; 2023 Nov; 46(6):1131-1138. PubMed ID: 37776278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
